Adenosine modulates n-methyl-d-aspartate-stimulated hippocampal nitric oxide production in vivo

Anish Bhardwaj, Frances Northington, Raymond C Koehler, Theodore Stiefel, Daniel F Hanley, Richard J. Traystman

Research output: Contribution to journalArticle

Abstract

and PurposeAdenosine acts presynaptically to inhibit release of excitatory amino acids (EAAs) and is thus considered to be neuroprotective. Because EAA-stimulated synthesis of nitric oxide (NO) may play an important role in long-term potentiation and excitotoxic-mediated injury, we tested the hypotheses that adenosine agonists attenuate basal and EAA-induced NO production in the hippocampus in vivo and that adenosine A1 receptors mediate this response. MethodsMicrodialysis probes were placed bilaterally into the CA3 region of the hippocampus of adult Sprague-Dawley rats under pentobarbital anesthesia. Probes were perfused for 5 hours with artificial cerebrospinal fluid containing 3 mu mol/L [sup 14 C]L-arginine. Recovery of [sup 14 C]L-citrulline in the effluent was used as a marker of NO production. In 10 groups of rats, time-dependent increases in [sup 14 C]L-citrulline recovery were compared between right- and left-sided probes perfused with various combinations of N-methyl-D-aspartate (NMDA), adenosine agonists, adenosine antagonists, and the NO synthase inhibitor Nomega -nitro-L-arginine methyl ester (L-NAME). ResultsRecovery of [sup 14 C]L-citrulline during perfusion with artificial cerebrospinal fluid progressively increased to 141 plus minus 27 fmol/min (plus minus SEM) over 5 hours. Contralateral perfusion with 1 mmol/L NMDA augmented [sup 14 C]L-citrulline recovery to 317 plus minus 62 fmol/min. Perfusion of 1 mmol/L L-NAME with NMDA inhibited [sup 14 C]L-citrulline recovery compared with NMDA alone. Perfusion with 0.1 mmol/L 2-chloroadenosine attenuated basal as well as NMDA-enhanced [sup 14 C]L-citrulline recovery. This action of 2-chloroadenosine was reversed by infusion of 0.1 mmol/L 8-cyclopentyl-1,3-dipropylxanthine, a specific A1 receptor antagonist. Infusion of 0.1 mmol/L (2S)-N6-[2-endo-norboryl]adenosine, a specific A1 receptor agonist, also attenuated the 0.1 mmol/L and 1 mmol/L NMDA-enhanced [sup 14 C]L-citrulline recovery. ConclusionsUsing an indirect method of assessing NO production in vivo, these data are consistent with in vitro results showing that NMDA receptor stimulation enhances NO production. Furthermore, we conclude that stimulation of A1 receptors can attenuate the basal as well as NMDA-induced production of NO. Because NMDA receptor stimulation amplifies glutamate release, our data are consistent with presynaptic A1 receptor-mediated inhibition of EAA release and consequent downregulation of NO production.

Original languageEnglish (US)
Pages (from-to)1627-1633
Number of pages7
JournalStroke
Volume26
Issue number9
StatePublished - 1995

Fingerprint

Citrulline
N-Methylaspartate
Aspartic Acid
Adenosine
Nitric Oxide
Excitatory Amino Acids
Perfusion
2-Chloroadenosine
NG-Nitroarginine Methyl Ester
N-Methyl-D-Aspartate Receptors
Cerebrospinal Fluid
Hippocampus
Presynaptic Receptors
Adenosine A1 Receptors
Long-Term Potentiation
Pentobarbital
Nitric Oxide Synthase
Sprague Dawley Rats
Arginine
Glutamic Acid

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Advanced and Specialized Nursing
  • Neuroscience(all)

Cite this

Adenosine modulates n-methyl-d-aspartate-stimulated hippocampal nitric oxide production in vivo. / Bhardwaj, Anish; Northington, Frances; Koehler, Raymond C; Stiefel, Theodore; Hanley, Daniel F; Traystman, Richard J.

In: Stroke, Vol. 26, No. 9, 1995, p. 1627-1633.

Research output: Contribution to journalArticle

@article{b1c795fb7b92482caf5d91ff9df94820,
title = "Adenosine modulates n-methyl-d-aspartate-stimulated hippocampal nitric oxide production in vivo",
abstract = "and PurposeAdenosine acts presynaptically to inhibit release of excitatory amino acids (EAAs) and is thus considered to be neuroprotective. Because EAA-stimulated synthesis of nitric oxide (NO) may play an important role in long-term potentiation and excitotoxic-mediated injury, we tested the hypotheses that adenosine agonists attenuate basal and EAA-induced NO production in the hippocampus in vivo and that adenosine A1 receptors mediate this response. MethodsMicrodialysis probes were placed bilaterally into the CA3 region of the hippocampus of adult Sprague-Dawley rats under pentobarbital anesthesia. Probes were perfused for 5 hours with artificial cerebrospinal fluid containing 3 mu mol/L [sup 14 C]L-arginine. Recovery of [sup 14 C]L-citrulline in the effluent was used as a marker of NO production. In 10 groups of rats, time-dependent increases in [sup 14 C]L-citrulline recovery were compared between right- and left-sided probes perfused with various combinations of N-methyl-D-aspartate (NMDA), adenosine agonists, adenosine antagonists, and the NO synthase inhibitor Nomega -nitro-L-arginine methyl ester (L-NAME). ResultsRecovery of [sup 14 C]L-citrulline during perfusion with artificial cerebrospinal fluid progressively increased to 141 plus minus 27 fmol/min (plus minus SEM) over 5 hours. Contralateral perfusion with 1 mmol/L NMDA augmented [sup 14 C]L-citrulline recovery to 317 plus minus 62 fmol/min. Perfusion of 1 mmol/L L-NAME with NMDA inhibited [sup 14 C]L-citrulline recovery compared with NMDA alone. Perfusion with 0.1 mmol/L 2-chloroadenosine attenuated basal as well as NMDA-enhanced [sup 14 C]L-citrulline recovery. This action of 2-chloroadenosine was reversed by infusion of 0.1 mmol/L 8-cyclopentyl-1,3-dipropylxanthine, a specific A1 receptor antagonist. Infusion of 0.1 mmol/L (2S)-N6-[2-endo-norboryl]adenosine, a specific A1 receptor agonist, also attenuated the 0.1 mmol/L and 1 mmol/L NMDA-enhanced [sup 14 C]L-citrulline recovery. ConclusionsUsing an indirect method of assessing NO production in vivo, these data are consistent with in vitro results showing that NMDA receptor stimulation enhances NO production. Furthermore, we conclude that stimulation of A1 receptors can attenuate the basal as well as NMDA-induced production of NO. Because NMDA receptor stimulation amplifies glutamate release, our data are consistent with presynaptic A1 receptor-mediated inhibition of EAA release and consequent downregulation of NO production.",
author = "Anish Bhardwaj and Frances Northington and Koehler, {Raymond C} and Theodore Stiefel and Hanley, {Daniel F} and Traystman, {Richard J.}",
year = "1995",
language = "English (US)",
volume = "26",
pages = "1627--1633",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Adenosine modulates n-methyl-d-aspartate-stimulated hippocampal nitric oxide production in vivo

AU - Bhardwaj, Anish

AU - Northington, Frances

AU - Koehler, Raymond C

AU - Stiefel, Theodore

AU - Hanley, Daniel F

AU - Traystman, Richard J.

PY - 1995

Y1 - 1995

N2 - and PurposeAdenosine acts presynaptically to inhibit release of excitatory amino acids (EAAs) and is thus considered to be neuroprotective. Because EAA-stimulated synthesis of nitric oxide (NO) may play an important role in long-term potentiation and excitotoxic-mediated injury, we tested the hypotheses that adenosine agonists attenuate basal and EAA-induced NO production in the hippocampus in vivo and that adenosine A1 receptors mediate this response. MethodsMicrodialysis probes were placed bilaterally into the CA3 region of the hippocampus of adult Sprague-Dawley rats under pentobarbital anesthesia. Probes were perfused for 5 hours with artificial cerebrospinal fluid containing 3 mu mol/L [sup 14 C]L-arginine. Recovery of [sup 14 C]L-citrulline in the effluent was used as a marker of NO production. In 10 groups of rats, time-dependent increases in [sup 14 C]L-citrulline recovery were compared between right- and left-sided probes perfused with various combinations of N-methyl-D-aspartate (NMDA), adenosine agonists, adenosine antagonists, and the NO synthase inhibitor Nomega -nitro-L-arginine methyl ester (L-NAME). ResultsRecovery of [sup 14 C]L-citrulline during perfusion with artificial cerebrospinal fluid progressively increased to 141 plus minus 27 fmol/min (plus minus SEM) over 5 hours. Contralateral perfusion with 1 mmol/L NMDA augmented [sup 14 C]L-citrulline recovery to 317 plus minus 62 fmol/min. Perfusion of 1 mmol/L L-NAME with NMDA inhibited [sup 14 C]L-citrulline recovery compared with NMDA alone. Perfusion with 0.1 mmol/L 2-chloroadenosine attenuated basal as well as NMDA-enhanced [sup 14 C]L-citrulline recovery. This action of 2-chloroadenosine was reversed by infusion of 0.1 mmol/L 8-cyclopentyl-1,3-dipropylxanthine, a specific A1 receptor antagonist. Infusion of 0.1 mmol/L (2S)-N6-[2-endo-norboryl]adenosine, a specific A1 receptor agonist, also attenuated the 0.1 mmol/L and 1 mmol/L NMDA-enhanced [sup 14 C]L-citrulline recovery. ConclusionsUsing an indirect method of assessing NO production in vivo, these data are consistent with in vitro results showing that NMDA receptor stimulation enhances NO production. Furthermore, we conclude that stimulation of A1 receptors can attenuate the basal as well as NMDA-induced production of NO. Because NMDA receptor stimulation amplifies glutamate release, our data are consistent with presynaptic A1 receptor-mediated inhibition of EAA release and consequent downregulation of NO production.

AB - and PurposeAdenosine acts presynaptically to inhibit release of excitatory amino acids (EAAs) and is thus considered to be neuroprotective. Because EAA-stimulated synthesis of nitric oxide (NO) may play an important role in long-term potentiation and excitotoxic-mediated injury, we tested the hypotheses that adenosine agonists attenuate basal and EAA-induced NO production in the hippocampus in vivo and that adenosine A1 receptors mediate this response. MethodsMicrodialysis probes were placed bilaterally into the CA3 region of the hippocampus of adult Sprague-Dawley rats under pentobarbital anesthesia. Probes were perfused for 5 hours with artificial cerebrospinal fluid containing 3 mu mol/L [sup 14 C]L-arginine. Recovery of [sup 14 C]L-citrulline in the effluent was used as a marker of NO production. In 10 groups of rats, time-dependent increases in [sup 14 C]L-citrulline recovery were compared between right- and left-sided probes perfused with various combinations of N-methyl-D-aspartate (NMDA), adenosine agonists, adenosine antagonists, and the NO synthase inhibitor Nomega -nitro-L-arginine methyl ester (L-NAME). ResultsRecovery of [sup 14 C]L-citrulline during perfusion with artificial cerebrospinal fluid progressively increased to 141 plus minus 27 fmol/min (plus minus SEM) over 5 hours. Contralateral perfusion with 1 mmol/L NMDA augmented [sup 14 C]L-citrulline recovery to 317 plus minus 62 fmol/min. Perfusion of 1 mmol/L L-NAME with NMDA inhibited [sup 14 C]L-citrulline recovery compared with NMDA alone. Perfusion with 0.1 mmol/L 2-chloroadenosine attenuated basal as well as NMDA-enhanced [sup 14 C]L-citrulline recovery. This action of 2-chloroadenosine was reversed by infusion of 0.1 mmol/L 8-cyclopentyl-1,3-dipropylxanthine, a specific A1 receptor antagonist. Infusion of 0.1 mmol/L (2S)-N6-[2-endo-norboryl]adenosine, a specific A1 receptor agonist, also attenuated the 0.1 mmol/L and 1 mmol/L NMDA-enhanced [sup 14 C]L-citrulline recovery. ConclusionsUsing an indirect method of assessing NO production in vivo, these data are consistent with in vitro results showing that NMDA receptor stimulation enhances NO production. Furthermore, we conclude that stimulation of A1 receptors can attenuate the basal as well as NMDA-induced production of NO. Because NMDA receptor stimulation amplifies glutamate release, our data are consistent with presynaptic A1 receptor-mediated inhibition of EAA release and consequent downregulation of NO production.

UR - http://www.scopus.com/inward/record.url?scp=0028981904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028981904&partnerID=8YFLogxK

M3 - Article

C2 - 7544925

AN - SCOPUS:0028981904

VL - 26

SP - 1627

EP - 1633

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 9

ER -